CompletedNot Applicable

Effect of Natural Compounds on the Severity of HPV-induced Cervical Lesions

Italy40 participantsStarted 2022-07-01

Plain-language summary

To test the efficacy of a newly-commercialized formula, 40 HPV-positive women displaying chronic cervicitis, mild dysplasia or moderate dysplasia. Women in the study group took one tablet per day containing 200 mg of EGCG, 400 mcg of Folic Acid, 1 mg of Vitamin B12 and 50 mg of Hyaluronic Acid for twelve weeks. Women in the control group received no treatment.

Who can participate

Age range18 Years – 55 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * HPV infections * Occurrence of low-grade cervical lesions Exclusion Criteria: * Diagnosis of malignancy or severe cervical lesions * Concurrent uterine pathologies * Pregnancy or intended to seek pregnancy in the next three months * Cancer

What they're measuring

Regression of cervical lesions

Timeframe: 12 weeks

Trial details

NCT IDNCT05625308

SponsorLo.Li.Pharma s.r.l

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2022-11-09

View on ClinicalTrials.gov More Papilloma trials